Articles & White Papers

Panitch Schwarze Partner Lars H. Genieser, Ph.D. Featured in The Journal of Intellectual Property Law & Practice

Partner Lars H. Genieser’s article ‘What patent practitioners can learn from Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.’ is featured in the Journal of Intellectual Property Law & Practice, 2021, Vol. 00, No. 0.

‘What patent practitioners can learn from Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.,’ enlightens readers on a decision made in the Nalpropion Pharms., Inc. v. Actavis Labs. FL, Inc., case.

Genieser is a registered patent attorney who focuses his patent prosecution practice on pharmaceuticals, biotechnology, and chemical, material science, and medical technologies. He successfully develops and implements worldwide patent protection strategies, prepares patentability and freedom-to-operate opinions, and prepares technology licenses.

To learn more about the case and decision click here.

 

Contact Us



By checking this box, I agree to the terms and conditions outlined on our Disclaimer page.
Email Disclaimer

Sending an email to our office does not create an attorney-client relationship, and none will be formed unless there is an expressed agreement between the firm and the client. Thus, we strongly advise against sending confidential or privileged information to us until you can establish such a relationship. Furthermore, we advise against sending privileged or confidential information through email at all, since we can in no way ensure the security of your email. In fact, neither this website nor the email system involved is encrypted, so you should not assume that your email is confidential. We cannot guarantee that someone else will not see it.

Do you agree to this Email Disclaimer?

I Agree I Do Not Agree